Smart Design of Nanostructures for Boosting Tumor Immunogenicity in Cancer Immunotherapy

Although tumor immunotherapy has emerged as a promising therapeutic method for oncology, it encounters several limitations, especially concerning low response rates and potential off-targets that elicit side effects. Furthermore, tumor immunogenicity is the critical factor that predicts the success...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Bohan, Wong, Wai-Ki, Ng, Yip-Ming, Yang, Mo, Leung, Franco King-Chi, Wong, Dexter Siu-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221856/
https://www.ncbi.nlm.nih.gov/pubmed/37242669
http://dx.doi.org/10.3390/pharmaceutics15051427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221856/
https://www.ncbi.nlm.nih.gov/pubmed/37242669
http://dx.doi.org/10.3390/pharmaceutics15051427

Ejemplares similares